Predictive Properties of the Asthma Control Test and Its Component Questions for Severe Asthma Exacerbations.

Predictive Properties of the Asthma Control Test and Its Component Questions for Severe Asthma Exacerbations.

J Allergy Clin Immunol Pract. 2016 Aug 17;

Authors: Cajigal S, Wells KE, Peterson EL, Ahmedani BK, Yang JJ, Kumar R, Burchard EG, Williams LK

Abstract
BACKGROUND: Current US guidelines recommend the Asthma Control Test (ACT) for assessing disease control and selecting treatment.
OBJECTIVE: The goal of this study was to prospectively assess the ACT and its component questions for their utility in predicting the risk of severe asthma exacerbations.
METHODS: Individuals were participants in the Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-Ethnicity, and those included in the current analysis had the following characteristics: age 18 years or more, physician-diagnosed asthma, and longitudinal care received at a large health system in southeastern Michigan. Study participants underwent a baseline evaluation, which included answering the ACT. A severe asthma exacerbation was defined as one requiring oral steroids, an emergency department visit, or inpatient admission. Receiver-operator characteristic curves were used to measure and compare the predictive utility of the ACT and its component questions for severe asthma exacerbations.
RESULTS: Of 1180 participants, 354 (30.0%) experienced a severe asthma exacerbation within 6 months of their baseline evaluation. When compared with the individual questions that composed the ACT, the composite score was significantly better at predicting severe exacerbations with 1 exception; the composite ACT score and the question assessing rescue medication use were not significantly different (P = .580). Pharmacy-based records of metered-dose inhaler short-acting beta-agonist use and asthma severity were also not significantly different from the composite ACT score.
CONCLUSIONS: Our study demonstrates that although the ACT is modestly predictive for exacerbations, the composite score may not be superior to assessing rescue medication use alone for predicting the risk of severe asthma exacerbations.

PMID: 27544712 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Yates fails drugs test using asthma inhaler – Eyewitness News


Eyewitness News

Yates fails drugs test using asthma inhaler
Eyewitness News
MELBOURNE – British rider Simon Yates, a strong contender to make Team GB's Olympic cycling squad, has failed a drugs test due to an "administrative error" over the use of an asthma inhaler, his team Orica-GreenEDGE said on Friday. The Bury-born …
Simon Yates fails drugs test after 'using asthma inhaler' to plunge British Cycling deeper into crisisTelegraph.co.uk
Simon Yates: British cyclist fails drug test 'after asthma inhaler error'BBC News
British cyclist Simon Yates fails drug test 'after asthma inhaler error'ITV News

all 43 news articles »

View full post on asthma – Google News

Simon Yates fails drugs test after ‘using asthma inhaler’ to plunge British Cycling deeper into crisis – Telegraph.co.uk


Telegraph.co.uk

Simon Yates fails drugs test after 'using asthma inhaler' to plunge British Cycling deeper into crisis
Telegraph.co.uk
A disastrous week got worse for British Cycling last night after it emerged that Simon Yates, the former points race world champion and a contender for a spot on the GB road team at Rio de Janeiro this summer, failed an in-competition drugs test
Yates fails drugs test using asthma inhaler: teamReuters
Simon Yates: British cyclist fails drug test 'after asthma inhaler error'BBC Sport
British cyclist Simon Yates fails drug test 'after asthma inhaler error'ITV News
Daily Mail –The Guardian
all 41 news articles »

View full post on asthma – Google News

Yates fails drugs test using asthma inhaler: team – Reuters


BBC News

Yates fails drugs test using asthma inhaler: team
Reuters
LONDON British rider Simon Yates, a strong contender to make Team GB's Olympic cycling squad, has failed a drugs test due to an "administrative error" over the use of an asthma inhaler, his team Orica-GreenEDGE said on Friday. The Bury-born 23-year-old …
Simon Yates: British cyclist fails drug test 'after asthma inhaler error'BBC News
British cyclist Simon Yates fails drug test 'after asthma inhaler error'ITV News
Cycling-Yates fails drugs test using asthma inhaler – teamDaily Mail

all 33 news articles »

View full post on asthma – Google News

Simon Yates: British cyclist fails drug test ‘after asthma inhaler error’ – BBC Sport


BBC Sport

Simon Yates: British cyclist fails drug test 'after asthma inhaler error'
BBC Sport
British cyclist Simon Yates has failed an in-competition drugs test – with his team blaming an "administrative error" over an asthma inhaler. Orica-GreenEdge said they took "full responsibility for the mistake" and there was "no wrongdoing" by Yates

and more »

View full post on asthma – Google News

Bedfont Scientific Recognizes World Asthma Day, Manufactures NObreath FeNO Test – Lung Disease News


Lung Disease News

Bedfont Scientific Recognizes World Asthma Day, Manufactures NObreath FeNO Test
Lung Disease News
United Kingdom-based Bedfont Scientific, which is celebrating four decades in business this year, is recognizing World Asthma Day on May. The company manufactures NObreath FeNO Test, a fractional exhaled nitric oxide (FeNO) breath analysis monitoring …

View full post on asthma – Google News

A simple asthma blood test may be in the works – CBS News


CBS News

A simple asthma blood test may be in the works
CBS News
Penn State researchers previously showed that chemicals in the lungs and blood called microRNAs — miRNAs for short — which may regulate proteins involved in allergic inflammation, could be used as asthma biomarkers. But the researchers didn't know if …
This biomarker can sort out asthma from allergiesFuturity: Research News

all 2 news articles »

View full post on asthma – Google News

MicroRNAs circulating in blood could lead to first diagnostic test for asthma – News-Medical.net

MicroRNAs circulating in blood could lead to first diagnostic test for asthma
News-Medical.net
People with asthma have telltale molecules circulating in their blood, say researchers at Penn State College of Medicine. The discovery could lead to the first diagnostic blood test for asthma, as well as more targeted treatments for the condition

View full post on asthma – Google News